tiprankstipranks

Simply Solventless Expands Debenture Financing and Confirms Bio-Tech Acquisition Date

Story Highlights
Simply Solventless Expands Debenture Financing and Confirms Bio-Tech Acquisition Date

Simply Solventless Concentrates Ltd ( (TSE:HASH) ) has issued an announcement.

Simply Solventless Concentrates Ltd has announced an increase in its previously planned convertible debenture financing from $5 million to $6 million due to high demand, with insiders contributing $375,000. This financing supports SSC’s acquisition plans, including the upcoming acquisition of Delta 9 Bio-Tech, expected to close around February 7, 2025, and another payment for a previous acquisition. The over subscription allows SSC to cover these costs without additional financing, potentially strengthening its market position.

More about Simply Solventless Concentrates Ltd

Simply Solventless Concentrates Ltd (SSC) operates in the cannabis industry, focusing on the production of solventless cannabis concentrates. The company is listed on the TSX Venture Exchange under the symbol HASH and is involved in strategic acquisitions to expand its market presence.

YTD Price Performance: -3.85%

Average Trading Volume: 374,996

Technical Sentiment Consensus Rating: Sell

Current Market Cap: C$67.04M

See more data about HASH stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App